ProQR Remains Confident In Pipeline After Sepofarsen Flop, Analysts Not So Much

 
• By Alaric DeArment
  
Eye
ProQR said its Phase II/III trial of sepofarsen in LBA10 failed • Source: Shutterstock

More from Sensory

More from Therapeutic Category